IL6 and hepatocellular carcinoma: Although some studies have evaluated the relation of PNPLA3 with IL-6 and IL-8 modulation in MASLD in vitro, no study has evaluated the association between HCC genetic predisposition measured by GRS and immune marker dysregulation in relation to these mutations and risk of HCC in patients with MASLD.22